These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37608545)

  • 1. Identification of potential
    Alotaibi BS; Hakami MA; Jawaid T; Alshammari N; Binsuwaidan R; Adnan M
    J Biomol Struct Dyn; 2024 Oct; 42(17):8885-8896. PubMed ID: 37608545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of promising anti-DNA gyrase antibacterial compounds using
    Islam MA; Pillay TS
    J Biomol Struct Dyn; 2020 Apr; 38(6):1798-1809. PubMed ID: 31084271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
    Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
    ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase: HQSAR, CoMSIA and molecular dynamics simulations.
    Kamsri P; Punkvang A; Hannongbua S; Suttisintong K; Kittakoop P; Spencer J; Mulholland AJ; Pungpo P
    SAR QSAR Environ Res; 2019 Nov; 30(11):775-800. PubMed ID: 31607177
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: structure-based virtual screening and molecular dynamics simulations approaches.
    Kalhor H; Sadeghi S; Marashiyan M; Kalhor R; Aghaei Gharehbolagh S; Akbari Eidgahi MR; Rahimi H
    J Biomol Struct Dyn; 2020 Feb; 38(3):791-806. PubMed ID: 30916622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.
    Mesleh MF; Cross JB; Zhang J; Kahmann J; Andersen OA; Barker J; Cheng RK; Felicetti B; Wood M; Hadfield AT; Scheich C; Moy TI; Yang Q; Shotwell J; Nguyen K; Lippa B; Dolle R; Ryan MD
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1314-8. PubMed ID: 26786695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents.
    Tari LW; Li X; Trzoss M; Bensen DC; Chen Z; Lam T; Zhang J; Lee SJ; Hough G; Phillipson D; Akers-Rodriguez S; Cunningham ML; Kwan BP; Nelson KJ; Castellano A; Locke JB; Brown-Driver V; Murphy TM; Ong VS; Pillar CM; Shinabarger DL; Nix J; Lightstone FC; Wong SE; Nguyen TB; Shaw KJ; Finn J
    PLoS One; 2013; 8(12):e84409. PubMed ID: 24386374
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Roney M; Issahaku AR; Forid MS; Huq AKMM; Soliman MES; Mohd Aluwi MFF; Tajuddin SN
    J Biomol Struct Dyn; 2023; 41(24):14904-14913. PubMed ID: 36995164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
    Azam MA; Thathan J
    SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
    Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
    Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, dynamic docking, synthesis, and
    Pudipeddi A; Vasudevan S; Shanmugam K; Mohan S S; Vairaprakash P; Neelakantan P; Balraj AS; Solomon AP
    J Biomol Struct Dyn; 2023; 41(13):6345-6358. PubMed ID: 35924774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of promising DNA GyrB inhibitors for Tuberculosis using pharmacophore-based virtual screening, molecular docking and molecular dynamics studies.
    Islam MA; Pillay TS
    Chem Biol Drug Des; 2017 Aug; 90(2):282-296. PubMed ID: 28109130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site.
    Franco-Ulloa S; La Sala G; Miscione GP; De Vivo M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of pharmacophore model to identify potential DNA gyrase inhibitors.
    Jakhar R; Khichi A; Kumar D; Sura K; Bhoomika ; Dangi M; Chhillar AK
    J Biomol Struct Dyn; 2023 Nov; 41(19):10125-10135. PubMed ID: 36473713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
    Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
    J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors.
    Nastasă C; Vodnar DC; Ionuţ I; Stana A; Benedec D; Tamaian R; Oniga O; Tiperciuc B
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis.
    Kashyap A; Singh PK; Silakari O
    Tuberculosis (Edinb); 2018 Sep; 112():83-88. PubMed ID: 30205973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introducing of novel class of pyrano[2,3-
    Almaghrabi M; Musa A; Aljohani AKB; Ahmed HEA; Alsulaimany M; Miski SF; Mostafa EM; Hussein S; Parambi DGT; Ghoneim MM; Elgammal WE; Halawa AH; Hammad A; El-Agrody AM
    J Biomol Struct Dyn; 2024 Nov; 42(18):9529-9546. PubMed ID: 37661733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B.
    Jukič M; Ilaš J; Brvar M; Kikelj D; Cesar J; Anderluh M
    Eur J Med Chem; 2017 Jan; 125():500-514. PubMed ID: 27689732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.